COSCIENS Biopharma Inc. COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc.

CSCI

Rank in Stocks #30075
COSCIENS Biopharma Inc., a life science company, develops and commercializes... COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Share Price
$5.61
Last synced: 2026-11-17
Market Cap
$5.60M
Change (1 day)
-3.80%
Change (1 year)
-12.10%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for COSCIENS Biopharma Inc. (CSCI)
EPS as of September 2026 TTM: $-11.41
According to COSCIENS Biopharma Inc.'s latest financial reports, its current EPS (TTM) is $-11.41. At the end of 2025 the company had an EPS of $-29.97, a decrease compared to its 2024 EPS of $-17.79.
EPS history for COSCIENS Biopharma Inc. from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-11.41 -61.93%
2025 $-29.97 68.47%
2024 $-17.79 213.76%
2023 $-5.67 -201.07%
2022 $5.61 40.60%
2021 $3.99 -32.83%
2020 $5.94 -107.54%
2019 $-78.75 -237.36%
2018 $57.33 -122.69%
2017 $-252.63 -53.44%
2016 $-542.61 -86.71%
2015 $-4.08K -35.35%
2014 $-6.31K -216.94%
2013 $5.40K -123.25%
2012 $-23.22K -39.94%
2011 $-38.67K -6.68%
2010 $-41.44K -29.42%
2009 $-58.71K -61.34%
2008 $-151.86K 85.21%
2007 $-81.99K -194.90%
2006 $86.40K 178.28%
2005 $31.05K -318.67%
2004 $-14.20K -79.17%
2003 $-68.16K 18.94%
2002 $-57.31K 503.17%
2001 $-9.50K -412.82%
2000 $3.04K 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$1.67 -114.64%
US
$1.90 -116.64%
SE
$6.83 -159.90%
FR
$0.02 -100.17%
HK
$2.81 -124.64%
IT

Questions about COSCIENS Biopharma Inc.'s earnings per share (EPS)

What is COSCIENS Biopharma Inc.'s earnings per share (EPS)?

COSCIENS Biopharma Inc.'s earnings per share (EPS) over the last twelve months is $-11.41, as of Sep 2026.

What was COSCIENS Biopharma Inc.'s earnings per share (EPS) in 2025?

In 2025, COSCIENS Biopharma Inc.'s earnings per share (EPS) was $-29.97, compared with $-17.79 in 2024.

How has COSCIENS Biopharma Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, COSCIENS Biopharma Inc.'s earnings per share (EPS) was highest in 2020 ($5.94) and lowest in 2025 ($-29.97).

How does COSCIENS Biopharma Inc.'s earnings per share (EPS) compare with similar companies?

COSCIENS Biopharma Inc.'s earnings per share (EPS) ($-11.41) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.83.